A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session04e2a1329c8a76eb731e7b46758e2e5994d297e9): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Radiopharmaceutical Solutions Market Insights, Forecast to 2034

img

Global Radiopharmaceutical Solutions Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Radiopharmaceutical Solutions Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Radiopharmaceutical Solutions Market
Global Radiopharmaceutical Solutions market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Radiopharmaceutical Solutions industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Radiopharmaceutical Solutions market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Radiopharmaceutical Solutions market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


IBA
GE Healthcare
Actinium Pharmaceuticals
Alseres Pharmaceuticals
Cardinal Health
Jubilant Pharma
Central Research Laboratories
Cyclomedica
Bracco
Eckert & Ziegler Radiopharma
Segment by Type
Oral Tracking
Vein Tracking

Segment by Application


Hospitals
Health Systems
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Radiopharmaceutical Solutions introduction, etc. Radiopharmaceutical Solutions Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Radiopharmaceutical Solutions
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Oral Tracking
1.2.3 Vein Tracking
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Health Systems
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Solutions Market Perspective (2018-2033)
2.2 Global Radiopharmaceutical Solutions Growth Trends by Region
2.2.1 Radiopharmaceutical Solutions Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Radiopharmaceutical Solutions Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceutical Solutions Forecasted Market Size by Region (2024-2033)
2.3 Radiopharmaceutical Solutions Market Dynamics
2.3.1 Radiopharmaceutical Solutions Industry Trends
2.3.2 Radiopharmaceutical Solutions Market Drivers
2.3.3 Radiopharmaceutical Solutions Market Challenges
2.3.4 Radiopharmaceutical Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Radiopharmaceutical Solutions by Players
3.1.1 Global Radiopharmaceutical Solutions Revenue by Players (2018-2023)
3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Radiopharmaceutical Solutions, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Radiopharmaceutical Solutions Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Solutions Revenue in 2022
3.5 Global Key Players of Radiopharmaceutical Solutions Head office and Area Served
3.6 Global Key Players of Radiopharmaceutical Solutions, Product and Application
3.7 Global Key Players of Radiopharmaceutical Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Solutions Breakdown Data by Type
4.1 Global Radiopharmaceutical Solutions Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2024-2033)
5 Radiopharmaceutical Solutions Breakdown Data by Application
5.1 Global Radiopharmaceutical Solutions Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Radiopharmaceutical Solutions Market Size (2018-2033)
6.2 North America Radiopharmaceutical Solutions Market Size by Type
6.2.1 North America Radiopharmaceutical Solutions Market Size by Type (2018-2023)
6.2.2 North America Radiopharmaceutical Solutions Market Size by Type (2024-2033)
6.2.3 North America Radiopharmaceutical Solutions Market Share by Type (2018-2033)
6.3 North America Radiopharmaceutical Solutions Market Size by Application
6.3.1 North America Radiopharmaceutical Solutions Market Size by Application (2018-2023)
6.3.2 North America Radiopharmaceutical Solutions Market Size by Application (2024-2033)
6.3.3 North America Radiopharmaceutical Solutions Market Share by Application (2018-2033)
6.4 North America Radiopharmaceutical Solutions Market Size by Country
6.4.1 North America Radiopharmaceutical Solutions Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
6.4.3 North America Radiopharmaceutical Solutions Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Radiopharmaceutical Solutions Market Size (2018-2033)
7.2 Europe Radiopharmaceutical Solutions Market Size by Type
7.2.1 Europe Radiopharmaceutical Solutions Market Size by Type (2018-2023)
7.2.2 Europe Radiopharmaceutical Solutions Market Size by Type (2024-2033)
7.2.3 Europe Radiopharmaceutical Solutions Market Share by Type (2018-2033)
7.3 Europe Radiopharmaceutical Solutions Market Size by Application
7.3.1 Europe Radiopharmaceutical Solutions Market Size by Application (2018-2023)
7.3.2 Europe Radiopharmaceutical Solutions Market Size by Application (2024-2033)
7.3.3 Europe Radiopharmaceutical Solutions Market Share by Application (2018-2033)
7.4 Europe Radiopharmaceutical Solutions Market Size by Country
7.4.1 Europe Radiopharmaceutical Solutions Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Radiopharmaceutical Solutions Market Size by Country (2018-2023)
7.4.3 Europe Radiopharmaceutical Solutions Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Radiopharmaceutical Solutions Market Size (2018-2033)
8.2 China Radiopharmaceutical Solutions Market Size by Type
8.2.1 China Radiopharmaceutical Solutions Market Size by Type (2018-2023)
8.2.2 China Radiopharmaceutical Solutions Market Size by Type (2024-2033)
8.2.3 China Radiopharmaceutical Solutions Market Share by Type (2018-2033)
8.3 China Radiopharmaceutical Solutions Market Size by Application
8.3.1 China Radiopharmaceutical Solutions Market Size by Application (2018-2023)
8.3.2 China Radiopharmaceutical Solutions Market Size by Application (2024-2033)
8.3.3 China Radiopharmaceutical Solutions Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Radiopharmaceutical Solutions Market Size (2018-2033)
9.2 Asia Radiopharmaceutical Solutions Market Size by Type
9.2.1 Asia Radiopharmaceutical Solutions Market Size by Type (2018-2023)
9.2.2 Asia Radiopharmaceutical Solutions Market Size by Type (2024-2033)
9.2.3 Asia Radiopharmaceutical Solutions Market Share by Type (2018-2033)
9.3 Asia Radiopharmaceutical Solutions Market Size by Application
9.3.1 Asia Radiopharmaceutical Solutions Market Size by Application (2018-2023)
9.3.2 Asia Radiopharmaceutical Solutions Market Size by Application (2024-2033)
9.3.3 Asia Radiopharmaceutical Solutions Market Share by Application (2018-2033)
9.4 Asia Radiopharmaceutical Solutions Market Size by Region
9.4.1 Asia Radiopharmaceutical Solutions Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Radiopharmaceutical Solutions Market Size by Region (2018-2023)
9.4.3 Asia Radiopharmaceutical Solutions Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Type
10.2.1 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Application
10.3.1 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Country
10.4.1 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IBA
11.1.1 IBA Company Details
11.1.2 IBA Business Overview
11.1.3 IBA Radiopharmaceutical Solutions Introduction
11.1.4 IBA Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.1.5 IBA Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Radiopharmaceutical Solutions Introduction
11.2.4 GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.2.5 GE Healthcare Recent Developments
11.3 Actinium Pharmaceuticals
11.3.1 Actinium Pharmaceuticals Company Details
11.3.2 Actinium Pharmaceuticals Business Overview
11.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.3.4 Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.3.5 Actinium Pharmaceuticals Recent Developments
11.4 Alseres Pharmaceuticals
11.4.1 Alseres Pharmaceuticals Company Details
11.4.2 Alseres Pharmaceuticals Business Overview
11.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Introduction
11.4.4 Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.4.5 Alseres Pharmaceuticals Recent Developments
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Radiopharmaceutical Solutions Introduction
11.5.4 Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.5.5 Cardinal Health Recent Developments
11.6 Jubilant Pharma
11.6.1 Jubilant Pharma Company Details
11.6.2 Jubilant Pharma Business Overview
11.6.3 Jubilant Pharma Radiopharmaceutical Solutions Introduction
11.6.4 Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.6.5 Jubilant Pharma Recent Developments
11.7 Central Research Laboratories
11.7.1 Central Research Laboratories Company Details
11.7.2 Central Research Laboratories Business Overview
11.7.3 Central Research Laboratories Radiopharmaceutical Solutions Introduction
11.7.4 Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.7.5 Central Research Laboratories Recent Developments
11.8 Cyclomedica
11.8.1 Cyclomedica Company Details
11.8.2 Cyclomedica Business Overview
11.8.3 Cyclomedica Radiopharmaceutical Solutions Introduction
11.8.4 Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.8.5 Cyclomedica Recent Developments
11.9 Bracco
11.9.1 Bracco Company Details
11.9.2 Bracco Business Overview
11.9.3 Bracco Radiopharmaceutical Solutions Introduction
11.9.4 Bracco Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.9.5 Bracco Recent Developments
11.10 Eckert & Ziegler Radiopharma
11.10.1 Eckert & Ziegler Radiopharma Company Details
11.10.2 Eckert & Ziegler Radiopharma Business Overview
11.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Introduction
11.10.4 Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2018-2023)
11.10.5 Eckert & Ziegler Radiopharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Radiopharmaceutical Solutions Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Oral Tracking
Table 3. Key Players of Vein Tracking
Table 4. Global Radiopharmaceutical Solutions Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Radiopharmaceutical Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Radiopharmaceutical Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Radiopharmaceutical Solutions Market Share by Region (2018-2023)
Table 8. Global Radiopharmaceutical Solutions Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Radiopharmaceutical Solutions Market Share by Region (2024-2033)
Table 10. Radiopharmaceutical Solutions Market Trends
Table 11. Radiopharmaceutical Solutions Market Drivers
Table 12. Radiopharmaceutical Solutions Market Challenges
Table 13. Radiopharmaceutical Solutions Market Restraints
Table 14. Global Radiopharmaceutical Solutions Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Radiopharmaceutical Solutions Revenue Share by Players (2018-2023)
Table 16. Global Top Radiopharmaceutical Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2022)
Table 17. Global Radiopharmaceutical Solutions Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Radiopharmaceutical Solutions Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Radiopharmaceutical Solutions, Headquarters and Area Served
Table 20. Global Key Players of Radiopharmaceutical Solutions, Product and Application
Table 21. Global Key Players of Radiopharmaceutical Solutions, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radiopharmaceutical Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2018-2023)
Table 25. Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2024-2033)
Table 27. Global Radiopharmaceutical Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Radiopharmaceutical Solutions Revenue Share by Application (2018-2023)
Table 29. Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Radiopharmaceutical Solutions Revenue Share by Application (2024-2033)
Table 31. North America Radiopharmaceutical Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Radiopharmaceutical Solutions Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Radiopharmaceutical Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Radiopharmaceutical Solutions Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Radiopharmaceutical Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Radiopharmaceutical Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Radiopharmaceutical Solutions Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Radiopharmaceutical Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Radiopharmaceutical Solutions Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Radiopharmaceutical Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Radiopharmaceutical Solutions Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Radiopharmaceutical Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Radiopharmaceutical Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Radiopharmaceutical Solutions Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Radiopharmaceutical Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Radiopharmaceutical Solutions Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Radiopharmaceutical Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Radiopharmaceutical Solutions Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Radiopharmaceutical Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Radiopharmaceutical Solutions Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Radiopharmaceutical Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Radiopharmaceutical Solutions Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Radiopharmaceutical Solutions Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Radiopharmaceutical Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Radiopharmaceutical Solutions Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size by Country (2024-2033) & (US$ Million)
Table 63. IBA Company Details
Table 64. IBA Business Overview
Table 65. IBA Radiopharmaceutical Solutions Product
Table 66. IBA Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 67. IBA Recent Developments
Table 68. GE Healthcare Company Details
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Radiopharmaceutical Solutions Product
Table 71. GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 72. GE Healthcare Recent Developments
Table 73. Actinium Pharmaceuticals Company Details
Table 74. Actinium Pharmaceuticals Business Overview
Table 75. Actinium Pharmaceuticals Radiopharmaceutical Solutions Product
Table 76. Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 77. Actinium Pharmaceuticals Recent Developments
Table 78. Alseres Pharmaceuticals Company Details
Table 79. Alseres Pharmaceuticals Business Overview
Table 80. Alseres Pharmaceuticals Radiopharmaceutical Solutions Product
Table 81. Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 82. Alseres Pharmaceuticals Recent Developments
Table 83. Cardinal Health Company Details
Table 84. Cardinal Health Business Overview
Table 85. Cardinal Health Radiopharmaceutical Solutions Product
Table 86. Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 87. Cardinal Health Recent Developments
Table 88. Jubilant Pharma Company Details
Table 89. Jubilant Pharma Business Overview
Table 90. Jubilant Pharma Radiopharmaceutical Solutions Product
Table 91. Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 92. Jubilant Pharma Recent Developments
Table 93. Central Research Laboratories Company Details
Table 94. Central Research Laboratories Business Overview
Table 95. Central Research Laboratories Radiopharmaceutical Solutions Product
Table 96. Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 97. Central Research Laboratories Recent Developments
Table 98. Cyclomedica Company Details
Table 99. Cyclomedica Business Overview
Table 100. Cyclomedica Radiopharmaceutical Solutions Product
Table 101. Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 102. Cyclomedica Recent Developments
Table 103. Bracco Company Details
Table 104. Bracco Business Overview
Table 105. Bracco Radiopharmaceutical Solutions Product
Table 106. Bracco Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 107. Bracco Recent Developments
Table 108. Eckert & Ziegler Radiopharma Company Details
Table 109. Eckert & Ziegler Radiopharma Business Overview
Table 110. Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Product
Table 111. Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2018-2023) & (US$ Million)
Table 112. Eckert & Ziegler Radiopharma Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiopharmaceutical Solutions Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Radiopharmaceutical Solutions Market Share by Type: 2022 VS 2033
Figure 3. Oral Tracking Features
Figure 4. Vein Tracking Features
Figure 5. Global Radiopharmaceutical Solutions Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Radiopharmaceutical Solutions Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Health Systems Case Studies
Figure 9. Others Case Studies
Figure 10. Radiopharmaceutical Solutions Report Years Considered
Figure 11. Global Radiopharmaceutical Solutions Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Radiopharmaceutical Solutions Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Radiopharmaceutical Solutions Market Share by Region: 2022 VS 2033
Figure 14. Global Radiopharmaceutical Solutions Market Share by Players in 2022
Figure 15. Global Top Radiopharmaceutical Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Radiopharmaceutical Solutions Revenue in 2022
Figure 17. North America Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Radiopharmaceutical Solutions Market Share by Type (2018-2033)
Figure 19. North America Radiopharmaceutical Solutions Market Share by Application (2018-2033)
Figure 20. North America Radiopharmaceutical Solutions Market Share by Country (2018-2033)
Figure 21. United States Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Radiopharmaceutical Solutions Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Radiopharmaceutical Solutions Market Share by Type (2018-2033)
Figure 25. Europe Radiopharmaceutical Solutions Market Share by Application (2018-2033)
Figure 26. Europe Radiopharmaceutical Solutions Market Share by Country (2018-2033)
Figure 27. Germany Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Radiopharmaceutical Solutions Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Radiopharmaceutical Solutions Market Share by Type (2018-2033)
Figure 35. China Radiopharmaceutical Solutions Market Share by Application (2018-2033)
Figure 36. Asia Radiopharmaceutical Solutions Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Radiopharmaceutical Solutions Market Share by Type (2018-2033)
Figure 38. Asia Radiopharmaceutical Solutions Market Share by Application (2018-2033)
Figure 39. Asia Radiopharmaceutical Solutions Market Share by Region (2018-2033)
Figure 40. Japan Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Radiopharmaceutical Solutions Market Share by Country (2018-2033)
Figure 50. Brazil Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Radiopharmaceutical Solutions Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. IBA Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 57. GE Healthcare Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 58. Actinium Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 59. Alseres Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 60. Cardinal Health Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 61. Jubilant Pharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 62. Central Research Laboratories Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 63. Cyclomedica Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 64. Bracco Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 65. Eckert & Ziegler Radiopharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries